cytarabine has been researched along with propidium in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (30.00) | 18.2507 |
| 2000's | 6 (60.00) | 29.6817 |
| 2010's | 1 (10.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Banavali, SD; Bokari, SA; Finke, D; Gopal, V; Preisler, HD | 1 |
| Dörmer, P; Ellwart, JW | 1 |
| Bartkowiak, D; Baust, H; Högner, S; Nothdurft, W; Röttinger, EM | 1 |
| Buck, S; Ozgen, U; Ravindranath, Y; Savaşan, S | 1 |
| Barbier, M; Boutonnat, J; Ronot, X; Seigneurin, D | 1 |
| Chmielewski, JA; Low, PS; Reddy, JA; Turk, MJ | 1 |
| Bauer, W; Fritzer-Szekeres, M; Grusch, M; Hoechtl, T; Horvath, Z; Illmer, C; Krupitza, G; Mader, RM; Madlener, S; Saiko, P; Schott, H; Szekeres, T | 1 |
| Erker, T; Fritzer-Szekeres, M; Handler, N; Horvath, Z; Jaeger, W; Murias, M; Saiko, P; Szekeres, T | 1 |
| Bernhaus, A; Fritzer-Szekeres, M; Graser, G; Grusch, M; Horvath, Z; Jaeger, W; Ozsvar-Kozma, M; Pemberger, M; Saiko, P; Savinc, I; Szekeres, T | 1 |
| Harrison, JS; Studzinski, GP; Wang, X | 1 |
10 other study(ies) available for cytarabine and propidium
| Article | Year |
|---|---|
Multiparameter assessment of the cell cycle effects of bioactive and cytotoxic agents.
Topics: Animals; Bone Marrow; Bromodeoxyuridine; Cell Cycle; Cell Nucleus; Cell Survival; Cells, Cultured; Chickens; Cytarabine; DNA Replication; DNA, Neoplasm; G1 Phase; G2 Phase; Interferon alpha-2; Interferon-alpha; Kinetics; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Mitosis; Propidium; Recombinant Proteins; S Phase; Tretinoin; Tumor Cells, Cultured | 1992 |
Vitality measurement using spectrum shift in Hoechst 33342 stained cells.
Topics: Animals; Benzimidazoles; Cell Separation; Cell Survival; Cytarabine; DNA; DNA Damage; Flow Cytometry; Interleukin-3; Mice; Propidium; Spectrometry, Fluorescence; Staining and Labeling; Tumor Cells, Cultured | 1990 |
Comparative analysis of apoptosis in HL60 detected by annexin-V and fluorescein-diacetate.
Topics: Annexin A5; Apoptosis; Cell Separation; Cytarabine; Flow Cytometry; Fluoresceins; HL-60 Cells; Hot Temperature; Humans; Propidium; Scattering, Radiation; Topotecan | 1999 |
Comparison of DiOC(6)(3) uptake and annexin V labeling for quantification of apoptosis in leukemia cells and non-malignant T lymphocytes from children.
Topics: Annexin A5; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Apoptosis; Carbocyanines; Child; Cytarabine; Daunorubicin; Flow Cytometry; Fluorescent Dyes; HL-60 Cells; Humans; Indicators and Reagents; Leukemia; Propidium; T-Lymphocytes; Tumor Cells, Cultured; U937 Cells; Vincristine | 2000 |
Nucleus labeling or membrane labeling for studying the proliferation of drug treated cells?
Topics: Acute Disease; Antineoplastic Agents; Cell Cycle; Cell Division; Cell Membrane; Cell Membrane Permeability; Cell Nucleus; Cytarabine; Daunorubicin; DNA, Neoplasm; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Flow Cytometry; Fluorescent Dyes; Humans; K562 Cells; Leukemia, Myeloid; Propidium | 2000 |
Characterization of a novel pH-sensitive peptide that enhances drug release from folate-targeted liposomes at endosomal pHs.
Topics: Amino Acid Sequence; Cholesterol; Cytarabine; Dextrans; Drug Delivery Systems; Endosomes; Fatty Acids, Monounsaturated; Folic Acid; Genetic Therapy; Genetic Vectors; Humans; Hydrogen-Ion Concentration; Liposomes; Molecular Sequence Data; Peptides; Permeability; Propidium; Quaternary Ammonium Compounds; Transfection; Tumor Cells, Cultured | 2002 |
Cytotoxic and apoptotic effects of novel heterodinucleoside phosphates consisting of 5-fluorodeoxyuridine and Ara-C in human cancer cell lines.
Topics: Antimetabolites, Antineoplastic; Apoptosis; Bisbenzimidazole; Cell Line, Tumor; Colonic Neoplasms; Coloring Agents; Cytarabine; Dimerization; Dinucleoside Phosphates; Fluorescent Dyes; Fluorouracil; Humans; Inhibitory Concentration 50; Lymphoma; Propidium | 2004 |
Antitumor effects of 3,3',4,4',5,5'-hexahydroxystilbene in HL-60 human promyelocytic leukemia cells.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bisbenzimidazole; Cell Cycle; Cytarabine; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Drug Synergism; Fluorescent Dyes; HL-60 Cells; Humans; Inhibitory Concentration 50; Leukemia, Promyelocytic, Acute; Propidium; Pyrogallol; Stilbenes | 2006 |
Biochemical effects of piceatannol in human HL-60 promyelocytic leukemia cells--synergism with Ara-C.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Cell Cycle; Cytarabine; Drug Screening Assays, Antitumor; Drug Synergism; Enzyme Inhibitors; HL-60 Cells; Humans; Leukemia, Promyelocytic, Acute; Models, Chemical; Propidium; Ribonucleotide Reductases; Stilbenes; Time Factors | 2008 |
Enhancement of arabinocytosine (AraC) toxicity to AML cells by a differentiation agent combination.
Topics: Abietanes; Annexin A5; Antimetabolites, Antineoplastic; Antioxidants; Apoptosis; Cell Cycle Checkpoints; Cell Cycle Proteins; Cell Differentiation; Comet Assay; Cytarabine; DNA Damage; Ergocalciferols; HL-60 Cells; Humans; Leukemia, Myeloid, Acute; Phosphorylation; Propidium; U937 Cells | 2016 |